SF 4089

Introduction - 94th Legislature (2025 - 2026)

Posted on 03/05/2026 09:22 a.m.

A bill for an act
relating to health; establishing requirements for education and training on vaccine
administration to prevent shoulder injuries related to vaccine administration;
appropriating money; amending Minnesota Statutes 2024, sections 150A.055,
subdivision 2; 151.01, subdivision 27; proposing coding for new law in Minnesota
Statutes, chapter 145.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

Section 1.

new text begin [145.676] SIRVA PREVENTION ACTIVITIES.
new text end

new text begin Subdivision 1. new text end

new text begin Definition. new text end

new text begin For purposes of this section, "shoulder injury related to vaccine
administration" or "SIRVA" has the meaning given in Code of Federal Regulations, title
42, section 100.3(c)(10).
new text end

new text begin Subd. 2. new text end

new text begin SIRVA prevention poster. new text end

new text begin All health clinics, pharmacies, and other health
care settings where vaccines are administered must display a poster created or approved by
the commissioner of health that describes proper vaccine administration techniques to
prevent shoulder injury related to vaccine administration. The poster must be displayed at
one or more locations in the clinic, pharmacy, or health care setting where the poster is
visible to the public and all health care personnel authorized to administer vaccines at the
clinic, pharmacy, or health care setting.
new text end

new text begin Subd. 3. new text end

new text begin Training. new text end

new text begin In order to administer vaccines on or after July 1, 2026, health care
personnel otherwise authorized to administer vaccines must complete comprehensive,
competency-based training on vaccine administration. The training must conform with the
guidance of the Centers for Disease Control and Prevention on vaccine administration and
must at least address vaccine preparation, proper needle selection, site and route selection,
administration, and SIRVA as a potentially serious complication resulting from improper
vaccine administration. After completing the training, health care personnel must submit
evidence of completion to the health-related licensing board that regulates the health care
personnel.
new text end

new text begin Subd. 4. new text end

new text begin Exceptions. new text end

new text begin This section does not apply to veterinary clinics, veterinary
hospitals, licensed veterinarians, or licensed veterinary technicians.
new text end

Sec. 2.

Minnesota Statutes 2024, section 150A.055, subdivision 2, is amended to read:

Subd. 2.

Qualified dentists.

(a) The vaccine shall be administered only to eligible
patients 16 years of age and older and only by licensed dentists who:

(1) have immediate access to emergency response equipment, including but not limited
to oxygen administration equipment, epinephrine, and other allergic reaction response
equipment; and

(2) are trained in or have successfully completed an educational program on vaccine
administration that is approved by the Minnesota Board of Dentistry, specifically for the
administration of vaccines. The training or program must new text begin comply with the requirements in
section 145.676, subdivision 3, and must new text end include:

(i) educational material on the disease and vaccination as prevention of the disease;

(ii) contraindications and precautions;

(iii) intramuscular administration;

(iv) communication of risk and benefits of vaccination and legal requirements involved;

(v) reporting of adverse events;

(vi) documentation required by federal law; and

(vii) storage and handling of vaccines.

(b) Any dentist giving vaccinations under this section shall comply with guidelines
established by the federal Advisory Committee on Immunization Practices relating to
vaccines and immunizations, which includes, but is not limited to, vaccine storage and
handling, vaccine administration and documentation, and vaccine contraindications and
precautions.

Sec. 3.

Minnesota Statutes 2024, section 151.01, subdivision 27, is amended to read:

Subd. 27.

Practice of pharmacy.

"Practice of pharmacy" means:

(1) interpretation and evaluation of prescription drug orders;

(2) compounding, labeling, and dispensing drugs and devices (except labeling by a
manufacturer or packager of nonprescription drugs or commercially packaged legend drugs
and devices);

(3) participation in clinical interpretations and monitoring of drug therapy for assurance
of safe and effective use of drugs, including ordering and performing laboratory tests that
are waived under the federal Clinical Laboratory Improvement Act of 1988, United States
Code, title 42, section 263a et seq. A pharmacist may collect specimens, interpret results,
notify the patient of results, and refer the patient to other health care providers for follow-up
care and may initiate, modify, or discontinue drug therapy only pursuant to a protocol or
collaborative practice agreement. A pharmacist may delegate the authority to administer
tests under this clause to a pharmacy technician or pharmacy intern. A pharmacy technician
or pharmacy intern may perform tests authorized under this clause if the technician or intern
is working under the direct supervision of a pharmacist;

(4) participation in drug and therapeutic device selection; drug administration for first
dosage and medical emergencies; intramuscular and subcutaneous drug administration under
a prescription drug order; drug regimen reviews; and drug or drug-related research;

(5) drug administration, through intramuscular and subcutaneous administration used
to treat mental illnesses as permitted under the following conditions:

(i) upon the order of a prescriber and the prescriber is notified after administration is
complete; or

(ii) pursuant to a protocol or collaborative practice agreement as defined by section
151.01, subdivisions 27b and 27c, and participation in the initiation, management,
modification, administration, and discontinuation of drug therapy is according to the protocol
or collaborative practice agreement between the pharmacist and a dentist, optometrist,
physician, physician assistant, podiatrist, or veterinarian, or an advanced practice registered
nurse authorized to prescribe, dispense, and administer under section 148.235. Any changes
in drug therapy or medication administration made pursuant to a protocol or collaborative
practice agreement must be documented by the pharmacist in the patient's medical record
or reported by the pharmacist to a practitioner responsible for the patient's care;

(6) initiating, ordering, and administering influenza and COVID-19 or SARS-CoV-2
vaccines authorized or approved by the United States Food and Drug Administration to all
eligible individuals three years of age and older and all other United States Food and Drug
Administration-approved vaccines to patients six years of age and older according to the
federal Advisory Committee on Immunization Practices recommendations. new text begin A pharmacist
administering vaccines under this clause must have completed training that complies with
the requirements in section 145.676, subdivision 3. new text end A pharmacist may delegate the authority
to administer vaccines under this clause to a pharmacy technician or pharmacy intern who
has completed training in vaccine administration new text begin that complies with the requirements in
section 145.676, subdivision 3, new text end if:

(i) the pharmacist and the pharmacy technician or pharmacy intern have successfully
completed a program approved by the Accreditation Council for Pharmacy Education
(ACPE) specifically for the administration of immunizations or a program approved by the
board;

(ii) the pharmacist utilizes the Minnesota Immunization Information Connection to
assess the immunization status of individuals prior to the administration of vaccines, except
when administering influenza vaccines to individuals age nine and older;

(iii) the pharmacist reports the administration of the immunization to the Minnesota
Immunization Information Connection;

(iv) if the patient is 18 years of age or younger, the pharmacist, pharmacy technician,
or pharmacy intern informs the patient and any adult caregiver accompanying the patient
of the importance of a well-child visit with a pediatrician or other licensed primary care
provider; and

(v) in the case of a pharmacy technician administering vaccinations while being
supervised by a licensed pharmacist:

(A) the supervision is in-person and must not be done through telehealth as defined
under section 62A.673, subdivision 2;

(B) the pharmacist is readily and immediately available to the immunizing pharmacy
technician;

(C) the pharmacy technician has a current certificate in basic cardiopulmonary
resuscitation;

(D) the pharmacy technician has completed a minimum of two hours of ACPE-approved,
immunization-related continuing pharmacy education as part of the pharmacy technician's
two-year continuing education schedule; and

(E) the pharmacy technician has completed one of two training programs listed under
Minnesota Rules, part 6800.3850, subpart 1h, item B;

(7) participation in the initiation, management, modification, and discontinuation of
drug therapy according to a written protocol or collaborative practice agreement between:
(i) one or more pharmacists and one or more dentists, optometrists, physicians, physician
assistants, podiatrists, or veterinarians; or (ii) one or more pharmacists and one or more
physician assistants authorized to prescribe, dispense, and administer under chapter 147A,
or advanced practice registered nurses authorized to prescribe, dispense, and administer
under section 148.235. Any changes in drug therapy made pursuant to a protocol or
collaborative practice agreement must be documented by the pharmacist in the patient's
medical record or reported by the pharmacist to a practitioner responsible for the patient's
care;

(8) participation in the storage of drugs and the maintenance of records;

(9) patient counseling on therapeutic values, content, hazards, and uses of drugs and
devices;

(10) offering or performing those acts, services, operations, or transactions necessary
in the conduct, operation, management, and control of a pharmacy;

(11) participation in the initiation, management, modification, and discontinuation of
therapy with opiate antagonists, as defined in section 604A.04, subdivision 1, pursuant to:

(i) a written protocol as allowed under clause (7); or

(ii) a written protocol with a community health board medical consultant or a practitioner
designated by the commissioner of health, as allowed under section 151.37, subdivision 13;

(12) prescribing self-administered hormonal contraceptives; nicotine replacement
medications; and opiate antagonists for the treatment of an acute opiate overdose pursuant
to section 151.37, subdivision 14, 15, or 16;

(13) participation in the placement of drug monitoring devices according to a prescription,
protocol, or collaborative practice agreement;

(14) prescribing, dispensing, and administering drugs for preventing the acquisition of
human immunodeficiency virus (HIV) if the pharmacist meets the requirements in section
151.37, subdivision 17; and

(15) ordering, conducting, and interpreting laboratory tests necessary for therapies that
use drugs for preventing the acquisition of HIV, if the pharmacist meets the requirements
in section 151.37, subdivision 17.

Sec. 4. new text begin APPROPRIATION; SIRVA PREVENTION POSTER.
new text end

new text begin $....... in fiscal year 2027 is appropriated from the general fund to the commissioner of
health to:
new text end

new text begin (1) create or approve a poster to educate health care personnel and the public about
proper vaccine administration techniques to prevent shoulder injury related to vaccine
administration (SIRVA); and
new text end

new text begin (2) make this poster available for display in all health care settings where vaccines are
administered.
new text end

new text begin This is a onetime appropriation.
new text end